An Follow-Up Study of Liver Cirrhosis

NCT03472742 · clinicaltrials.gov ↗

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Decompensated Liver Cirrhosis

Interventions

DRUG: Mesenchymal Stem Cell

Sponsor

Rohto Pharmaceutical Co., Ltd.